Insmed (INSM) PT Raised to $121 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Insmed (INSM) PT Raised to $110 at Evercore ISI
June 11, 2025 5:14 AM EDTEvercore ISI analyst Liisa Bayko raised the price target on Insmed (NASDAQ: INSM) to $110.00 (from $90.00) while maintaining a Outperform rating.
The analyst comments "INSM delivered outstanding data on BOTH PVR & 6MWD, handedly beating our and investor expectations, which were already... More



